ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogsGuiqiang Wang, Jinzi J. Wu, Yimin Cui et al.|Journal of Hepatology|2022Cited by 20
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 TrialYanhang Gao, Junqi Niu, Yanzhong Peng et al.|Clinical Infectious Diseases|2021Cited by 15
Pradefovir in naive or experienced adult patients with chronic infection of hepatitis B virus: week24 results from 23 multicentre, double-blind, randomised, non-inferiority, phase2 trialsYanhang Gao, Junqi Niu, Fei Kong et al.|Journal of Hepatology|2020Cited by 0